
Cogenics
About Cogenics
Cogenics is a Healthcare company, and was acquired by Beckman Coulter in April 2009. Gene synthesis, sequencing, and molecular biology services are provided.
Company details
Gene synthesis, sequencing, and molecular biology services are offered by Cogenics in the biotechnology sector. Next-generation sequencing, Sanger sequencing, PCR, and related techniques are encompassed within these offerings. Plasmid preparation, oligo synthesis, and nucleic acid extraction are included among the core services. Preclinical and clinical support is provided through GLP-compliant testing and CLIA-certified variant confirmation. Research in gene therapy, cancer, and infectious diseases is facilitated by these capabilities.
- Stage Acquired
- SectorsHealthcare
- Website cogenics.com
- Acquired by Beckman Coulter (Apr 2009)
- Investors
- Acquired byBeckman Coulter
(Apr 2009)
Investors in Cogenics
Cogenics has secured backing from 1 investor. Prominent investors backing the company include Beckman Coulter.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Clinical diagnostic products are manufactured for biomedical testing. | 1935 | beckmancoulter.com | Brea, United States |
Investor details for Cogenics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Web traffic of Cogenics
Websites that share an audience with Cogenics (cogenics.com).
Websites whose visitors overlap most with Cogenics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| beckmangenomics.com | 93% | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cogenics
Gene synthesis, sequencing, and molecular biology services are offered by Cogenics in the biotechnology sector. Next-generation sequencing, Sanger sequencing, PCR, and related techniques are encompassed within these offerings. Plasmid preparation, oligo synthesis, and nucleic acid extraction are included among the core services. Preclinical and clinical support is provided through GLP-compliant testing and CLIA-certified variant confirmation. Research in gene therapy, cancer, and infectious diseases is facilitated by these capabilities.
Cogenics has 1 investor. Key investors include Beckman Coulter.
Yes. Cogenics was acquired by Beckman Coulter in April 2009.